Next Generation Diabetes Therapy and Drug Delivery Market Revenue Analysis by 2023 - Global Players: Enteris BioPharma, Dexcom, Medtech, Sanofi

Next generation diabetes therapy and drug delivery devices are used to check the blood glucose levels and deliver insulin into the body. Next generation diabetes drug delivery systems, such as oral and inhalable insulin, help introduce insulin into the patients body without causing pain and reduce the risk of skin irritation, owing to frequent use of needles. Advancements in diabetes therapy systems, such as insulin patch, continuous glucose monitoring (CGM) system, and artificial pancreas, are frequently used to detect the glucose levels and adjust the insulin levels to manage the change in glucose levels.

The global market was valued at $617 million in 2015 and is expected to garner $9,673 million by 2022, registering a CAGR of 41.1% during the forecast period 2016 - 2023. North America is the highest contributor in the next generation diabetes therapy and drug delivery market; however, Asia-Pacific is witnessing the highest growth rate.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/2098

Rise in the number of diabetics and the benefits of using advanced diabetic devices, such as artificial pancreas and insulin patches over conventional products, are expected to boost the growth of next generation diabetes therapy and drug delivery market. Furthermore, the increase in disposable income among the diabetic patients and technological advancement of next generation diabetic products areanticipated to fuel the market growth.

The rise in healthcare expenditure in the developing countries, such as India and China, is expected to provide opportunities for market expansion. However, lack of awareness, less variability in products, and cost restrains in the developing regions are expected to hamper the market growth.

Market Leaders:

• Medtronic Inc.
• Sanofi
• Novo Nordisk
• MannKind Corporation
• Enteris BioPharma
• Dexcom Inc.
• Senseonics Holding Inc.
• Medtech

Key Findings of Next Generation Diabetes Therapy and Drug Delivery Market:
• Artificial pancreas segment is projected to grow at the highest rate during the analysis period.
• CGM system was the highest revenue-generating segment, and is expected to continue its dominance in future.
• North America dominated global next generation diabetes therapy and drug delivery market, and is projected to grow at a CAGR of 40%.
• India is expected to grow highest in the Asia-Pacific region, registering a CAGR of 51.1%.
• Diagnostic/clinic segment was the highest end user contributor towards the market during the analysis period.

Send Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2098

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.